David Gerring
Corporate Officer/Principal chez ARECOR THERAPEUTICS PLC
Fortune : 313 023 $ au 31/05/2024
Profil
David Gerring has held positions as Vice President of Development at Arecor Ltd.
and Vice President of Business Development at Arecor Therapeutics Plc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARECOR THERAPEUTICS PLC
0,50% | 16/11/2022 | 154 626 ( 0,50% ) | 313 023 $ | 31/05/2024 |
Postes actifs de David Gerring
| Sociétés | Poste | Début |
|---|---|---|
| ARECOR THERAPEUTICS PLC | Corporate Officer/Principal | - |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARECOR THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
